Article thumbnail

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

By Jessica Erriquez, M Olivero, Gloria Mittica, Ms Scalzo, M Vaira, M De Simone, R Ponzone, D Katsaros, Massimo Aglietta, Raffaele Adolfo Calogero, Maria Flavia Di Renzo and Giorgio Valabrega
Topics: chemotherapy; ovarian cancer; patient derived xenograft
Publisher: 'Impact Journals, LLC'
Year: 2016
DOI identifier: 10.18632/oncotarget.8325
OAI identifier: oai:iris.unito.it:2318/1589539

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.